Klaus Brischwein
- Oncology top 2%
- Radiology, Nuclear Medicine and Imaging top 2%
- Immunology top 5%
- Molecular Biology
- Public Health, Environmental and Occupational Health top 10%
- Co-authors
- Patrick A. BaeuerlePeter KuferBernd SchlerethRobert HofmeisterPatrick HoffmannNadja PrangChristian BrandlRalf C. Bargou
- Topics
- Monoclonal and Polyclonal Antibodies Research (14 papers)CAR-T cell therapy research (12 papers)Glycosylation and Glycoproteins Research (4 papers)
- Partner nations
- GermanySwitzerlandUnited States
In The Last Decade
Klaus Brischwein
20 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 69
- Oncology 1.1k
- Radiology, Nuclear Medicine and Imaging 728
- Immunology 582
- Molecular Biology 451
- Public Health, Environmental and Occupational Health 146
Countries citing papers authored by Klaus Brischwein
This map shows the geographic impact of Klaus Brischwein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Klaus Brischwein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Klaus Brischwein more than expected).
Fields of papers citing papers by Klaus Brischwein
This network shows the impact of papers produced by Klaus Brischwein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Klaus Brischwein. The network helps show where Klaus Brischwein may publish in the future.
Co-authorship network of co-authors of Klaus Brischwein
This figure shows the co-authorship network connecting the top 25 collaborators of Klaus Brischwein. A scholar is included among the top collaborators of Klaus Brischwein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Klaus Brischwein. Klaus Brischwein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 144 | |
| 2 | 43 | |
| 3 | 30 | |
| 4 | 16 | |
| 5 | Therapeutic window of MuS110, a single-chain antibody construct bispecific for EpCAM (CD326) and CD3 | 3 |
| 6 | 103 | |
| 7 | 146 | |
| 8 | Mode of action of MT110, a novel bispecific single-chain antibody construct of the BiTE class for treatment of adeno and squamous cell carcinoma expressing EpCAM (CD326) | 1 |
| 9 | 10 | |
| 10 | 77 | |
| 11 | 212 | |
| 12 | 123 | |
| 13 | 101 | |
| 14 | 264 | |
| 15 | 44 | |
| 16 | 34 | |
| 17 | Induction of drug resistance and protein kinase C genes in A2780 ovarian cancer cells after incubation with antineoplastic agents at sublethal concentrations. | 23 |
| 18 | 19 | |
| 19 | 24 | |
| 20 | 9 |
About Klaus Brischwein
Klaus Brischwein is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Immunology, having authored 21 papers that have together received 1.5k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (14 papers), CAR-T cell therapy research (12 papers) and Glycosylation and Glycoproteins Research (4 papers). The work is most often cited by research in Oncology (1.1k citations), Radiology, Nuclear Medicine and Imaging (728 citations) and Immunology (582 citations). Klaus Brischwein has collaborated with scholars based in Germany, Switzerland and United States. Frequent co-authors include Patrick A. Baeuerle, Peter Kufer, Bernd Schlereth, Robert Hofmeister, Patrick Hoffmann, Nadja Prang, Christian Brandl, Ralf C. Bargou, Christian Itin and Mathias Locher. Their work appears in journals such as Cancer Research, FEBS Letters and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.